Sitagliptin

Composition

Each tablet contains sitagliptin phosphate monohydrate, equivalent to 25mg, 50mg, and 100mg sitagliptin

Indications

It is indicated to control high blood sugar levels in patients with type 2 diabetes.

Side effects

Mild to moderate side effects have been observed such as upset stomach diarrhea upper respiratory infection runny nose and sore throat joint pain, Pancreatitis, Bullous phemphigoid, muscle pain

Precautions

This drug is to be cautiously used in patients with kidney problems, a history of pancreatitis, pregnant women and breastfeeding, previous swelling of the tongue, face, lips, breathing difficulty

Contraindications

It is contraindicated in people with kidney problems, pancreatitis, diabetic ketoacidosis type 1 diabetes

Dosage and administration

In adults the usual dose consists of a tablet of 100 mg to be given orally once daily with or without food

Countries

We have also established roots and begun this new venture in other countries as well such as Libya, France , Oman, Brazil, Finland

Available Forms

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai